Navigation Links
Center for Proteomics at the Translational Genomics Research Institute (TGen) Selected as Waters Center of Innovation
Date:8/26/2011

MILFORD, Mass., Aug. 26, 2011 /PRNewswire/ -- Waters Corporation (NYSE: WAT) today recognized the Center for Proteomics at the Translational Genomics Research Institute (TGen) as a Waters Center of Innovation.

(Logo: http://photos.prnewswire.com/prnh/20110707/NE31586LOGO)

In particular, Waters recognized Dr. Konstantinos Petritis, Head of TGen's Center for Proteomics, and his team for their leadership in the research of proteomics and biomarker discovery and verification.

In a ceremony at TGen's headquarters in Phoenix, Ariz., TGen President and Research Director Dr. Jeffrey Trent told TGen employees and representatives from Waters Corporation that TGen is moving with a great sense of urgency toward helping cancer patients.

"Whether it's through our discovery-based research or our clinical programs, our focus is to provide patient benefit as quickly as we can. My hope and expectation is that in many unique ways the Waters Centers of Innovation Program will help us accelerate our research and further our goal of providing personalized medicine to each patient in the future," said Dr. Trent.

"It was Dr. Trent's vision for translational medicine that led us to the relationship we have with TGen today. By formalizing our relationship with them we want to help TGen achieve its objectives and make personalized medicine a reality, partly by taking technology to the next level. I look forward to doing good science together for years to come," said Mark Groudas, Waters Sr. Vice President, Americas Business Operations.

TGen is now among an elite group of fewer than 20 partners worldwide that are part of the Waters Centers of Innovation. While most of the member institutes of this circle are well
'/>"/>

SOURCE Waters Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. American Laser Centers Opens Three Minneapolis-St. Paul Area Clinics
2. Repair Stem Cell Institute Announces Industrys First Standards of Excellence for Global Stem Cell Treatment Centers to Protect Patients from Less-than-Competent Therapeutics
3. Truman Medical Centers Becomes One of the First Hospitals in the U.S. To Install the Worlds First Adaptive 128-slice CT Scanner
4. MD Anderson Becomes a GeneGo Center of Excellence Using MetaCore for Oncology Research
5. Moffitt Cancer Center Receives Prestigious SPORE Grant Worth More Than $10 Million
6. UT Knoxville Wins $16M Mathematics and Biology Center
7. The National Cancer Institute Joins the Global Community of Scientists Now Using BIOMARKERcenter From Thomson Reuters
8. New Hamner-UNC Center for Drug Safety Sciences
9. A Better Tomorrow Treatment Center Inc., Forterus Inc.s Behavioral Healthcare Subsidiary, is the First in the Nation to Offer DNA-Customized Treatment for Individuals with a Genetic Predisposition for Addictive Behavior
10. Presbyterian Cancer Center to Offer Cancer Patients High-End VMAT Treatments With the Installation of Elekta Infinity
11. Oklahoma CyberKnife Center Cuts Treatment Time in Half With Next Generation CyberKnife Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2015)... -- Findings presented at the European Organization ... of NeuroOncology (EANO) and European Society for Medical Oncology ... that EDO-S101 is effective in models of human glioblastoma ... radiotherapy (RT). [ 1 ] ... that combines the DNA damaging effect of bendamustine with ...
(Date:6/3/2015)... CIRTEC Medical Systems , a ... complex Class III implantable devices and minimally invasive devices, ... initiative aimed at identifying potentially marketable biomedical technologies developed ... moving them more efficiently from the laboratory bench to ... working with the world's largest OEMs and most innovative ...
(Date:6/3/2015)... , June 3, 2015  HireLifeScience.com, the premier ... will host its 6 th annual career ... at Raritan Center in Edison, NJ ... include Novo Nordisk, Covance, Actavis and AstraZeneca.  Additional ... be exhibiting are Johnson & Johnson, MedImmune, DSM ...
(Date:6/3/2015)... 03, 2015 Photo-Eyewear™ ( http://www.PhotoEyewear.com ... to PogoTec™, Inc. ( http://www.PogoTec.com ) to better ... device products and technologies it is developing and plans ... business divisions, PogoTec™ will provide focused resources to drive ... , , On-Track™ – There are ...
Breaking Biology Technology:Mundipharma EDO GmbH Data Confirm EDO-S101 is Effective in Preclinical Models of Human Glioblastoma 2Mundipharma EDO GmbH Data Confirm EDO-S101 is Effective in Preclinical Models of Human Glioblastoma 3Mundipharma EDO GmbH Data Confirm EDO-S101 is Effective in Preclinical Models of Human Glioblastoma 4CIRTEC Medical Systems to support new UT Dallas-led Initiative to deliver biomedical technologies from laboratory bench to bedside more efficiently 2AstraZeneca Added as Sponsor for Industry Leading Life Science Hiring Event 2Photo-Eyewear™ Changes Name to PogoTec™ and Announces Three Divisions 2Photo-Eyewear™ Changes Name to PogoTec™ and Announces Three Divisions 3
... Purpose , Researchers and ... currently employ immuno- or colourimetric assays. These assays suffer from a number of limitations: , ... They are not as commonly available for novel sample matrices such ... They can be relatively costly due to the high volume of ...
... of liquid chromatography/ mass spectrometry and information dependent data acquisition function ... to quantifying their parents during metabolic stability studies. This was once ... Abstract , ... triple quadrupole ion path and is capable of doing conventional multiple ...
... very straightforward method for the analysis of the very ... and monocrotophos in water has been developed. Large volume ... RP18 HPLC column with a polar endcapping. The compounds ... mass spectrometer operated in multiple reaction-monitoring mode. The detection ...
Cached Biology Technology:Simultaneous Screening of 23 Drugs of Abuse in Oral Fluid Using an LC/MS/MS Method 2Simultaneous Screening of 23 Drugs of Abuse in Oral Fluid Using an LC/MS/MS Method 3Simultaneous Screening of 23 Drugs of Abuse in Oral Fluid Using an LC/MS/MS Method 4Simultaneously characterizing and quantifying chloramphenicol and its metabolite using LC/MS/MS 2Simultaneously characterizing and quantifying chloramphenicol and its metabolite using LC/MS/MS 3Simultaneously characterizing and quantifying chloramphenicol and its metabolite using LC/MS/MS 4Simultaneously characterizing and quantifying chloramphenicol and its metabolite using LC/MS/MS 5Determination of Polar Organophosphorus Pesticides in Aqueous Samples by Direct Injection Using HPLC/MS/MS 2
(Date:5/19/2015)... Fingerprint Cards (FPC) has received an order for ... from one if its module partners. Deliveries are planned to ... the sensors will be used by smartphone manufacturers in ... amount to 740 MSEK to date. In addition to previously ... number of smaller orders not separately communicated amounting to more ...
(Date:5/14/2015)... , May 14, 2015 Research and Markets ... of the "Fingerprint Sensors Market in Smart Mobile ... This report believes that 2014 was a watershed year ... Apple,s introduction of ,Apple Pay,. Apple gave fingerprint sensors ... mobile payment service. Fingerprint sensors are a must-have feature ...
(Date:5/11/2015)... 11, 2015 Curemark LLC, a privately held ... a new Phase III double blind, randomized, placebo-controlled clinical ... CM-AT, on all children ages 3-8 with Autism. Previously, ... III double blinded clinical trial for CM-AT in children ... the digestive enzyme chymotrypsin. This new trial will help ...
Breaking Biology News(10 mins):Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 230 Million and Raises Revenue Guidance for 2015 2Global Smart Mobile Devices Fingerprint Sensors Market 2015-2019: Key Vendors are Authentec, Validity Sensors, Fingerprint Cards, Next Biometrics Group. IDEX, and Qualcomm 2Curemark, LLC, Launches New Phase III Trial in Expanded Population of Children with Autism 2
... 2013 The following statement is being issued by Robbins Geller Rudman ... Biosciences Securities Litigation SUPERIOR COURT OF THE STATE ... IN RE PACIFIC BIOSCIENCES OF CALIFORNIA , ... SUMMARY NOTICE OF PROPOSED SETTLEMENT OF CLASS ACTION Hon. Marie S. ...
... This news release is available in German . ... the current issue of the " Journal of Clinical Investigation " ... begin to fail with increasing age. As a result, signs of ... Alzheimer,s disease, diabetes, cardiovascular disorders and cancer, increases. "Current efforts to ...
... Developing ways to treat cancer patients with drugs that kill ... one of the topics in the premiere segment of the ... Chemical Society (ACS), the world,s largest scientific society. The videos ... DVD . Titled Prized Science: Peter Stang ...
Cached Biology News:Robbins Geller Rudman & Dowd LLP and Scott+Scott, Attorneys at Law, LLP Announce Proposed Settlement of Class Action in the Pacific Biosciences Securities Litigation 2Robbins Geller Rudman & Dowd LLP and Scott+Scott, Attorneys at Law, LLP Announce Proposed Settlement of Class Action in the Pacific Biosciences Securities Litigation 3Robbins Geller Rudman & Dowd LLP and Scott+Scott, Attorneys at Law, LLP Announce Proposed Settlement of Class Action in the Pacific Biosciences Securities Litigation 4Rapamycin: Limited anti-aging effects 2Rapamycin: Limited anti-aging effects 3American Chemical Society launches 2013 edition of popular Prized Science video series 2
Rabbit polyclonal to BCA1 ( Abpromise for all tested applications). Antigen: Generated using E.coli expressed mouse BCA1. Entrez GeneID: 10563 SWISS Protein ID: O43927...
SH3 Proteins II Sampler Kit 10g each...
Tumor Suppressor Sampler Kit 10 mu g each...
Human peripheral blood eosinophils, For immunohistochemistry (IHC) Cell Chip with Human Peripheral Blood Granulocytes...
Biology Products: